日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemo-photothermal synergy ignites antitumor immunity via ferroptosis

化疗-光热协同作用通过铁死亡激活抗肿瘤免疫。

Lin, Jundong; Yang, Huikang; Zou, Zhihao; Deng, Lizhi; Cai, Xiaoxia; Chen, Muqi; Xu, Jiaquan; Yin, Wenjun; Wen, Biyan; Xie, Wenjie; Xu, Qianfeng; Zhong, Guowei; Wu, Zhenjie; Chen, Yanfei; Zhang, Rihong; Tian, Weicheng; Zhang, Yixun; Long, Yusen; Li, Yize; Han, Zhaodong; Liang, Yuxiang; Ye, Jianheng; Lu, Jianming; Liang, Yingke; Dai, Qishan; Zou, Fen; He, Huichan; Zhong, Weide; Zhuo, Yangjia

Retraction Note: Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer

撤稿声明:在人类前列腺癌中鉴定出一种新型的microRNA-mRNA调控生物模块

Zhang, Yanqiong; Jiang, Funeng; He, Huichan; Ye, Jianheng; Mao, Xia; Guo, Qiuyan; Wu, Shu-Lin; Zhong, Weide; Wu, Chin-Lee; Lin, Na

Engineering endoplasmic reticulum targeted metal-polyphenol curcumin nanomicelles for melanoma therapy

构建靶向内质网的金属-多酚姜黄素纳米胶束用于黑色素瘤治疗

Zhang, Yixun; Wang, Xuehua; Zhang, Hongli; Zhou, Xin; He, Huichan; Zou, Fen; Zhuo, Yangjia; Cai, Zhouda; Xu, Qianfeng; Xie, Wenjie; Lin, Jundong; Chen, Muqi; Zheng, Wenlian; Chen, Jianwei; Liu, Jinsheng; Yang, Huikang; Zhong, Weide; Yang, Ronghua

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

乙酰辅酶A羧化酶1的耗竭通过激活MAPK/ERK通路促进前列腺癌细胞的上皮-间质转化

Lai Jiarun, Liu Shaoyou, Chen Yupeng, Chen Jian, Li Jinchuang, Liang Zhenguo, Mei Xinyue, Feng Yuanfa, Han Zhaodong, Jiang Funeng, Yang Shengbang, Wu Yongding, Tan Huijing, Liu Junchen, He Huichan, Zhong Weide

ACACA depletion activates the cPLA2-arachidonic acid-NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer.

ACACA 耗竭激活 cPLA2-花生四烯酸-NF-κB 轴,从而驱动雄激素受体非依赖性前列腺癌的炎症重编程

Liu Shaoyou, Chen Yupeng, Chen Jian, Li Jinchuang, Liang Zhenguo, Mei Xinyue, Feng Yuanfa, Han Zhaodong, Jiang Funeng, Wu Yongding, Tan Huijing, Luo Hongwei, He Huichan, Lai Jiarun, Zhong Weide

A Promising Prognostic Signature Consisting of Fatty Acid Metabolism Genes based on Machine Learning Predicts Biochemical Recurrence and Aids ARSI Therapy in Prostate Cancer

基于机器学习的脂肪酸代谢基因预后特征预测前列腺癌生化复发并辅助ARSI治疗

Wu, Zhenjie; Deng, Yulin; Feng, Yuanfa; Tan, Zeheng; Cai, Shanghua; He, Huichan; Yin, Wenjun; Li, Jinchuang; Tian, Weicheng; Lu, Jianming; Xie, Wenjie; Lin, Jundong; Ye, Jianheng; Han, Zhaodong; Zhong, Weide

Characterization of the Biochemical Recurrence Prediction Ability and Progression Correlation of Peroxiredoxins Family in Prostate Cancer Based on Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Cohorts.

基于整合单细胞 RNA-Seq 和批量 RNA-Seq 队列,对前列腺癌中过氧化物酶家族的生化复发预测能力和进展相关性进行表征

Tang Shan, Li Jinchuang, Tian Weicheng, Feng Yuanfa, Deng Yulin, Tan Zeheng, Han Zhaodong, He Huichan, Wu Yongding, Huang Chuyang, Ning Keping, Liu Feng, Luo Hongwei, Cai Shanghua, Ye Jianheng, Zhong Weide

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

靶向 FGFR1 可通过 MAPK 介导的 BRCA2 下调增强 mCRPC 对奥拉帕尼的敏感性。

Chen Jian, Lai Jiarun, Chen Yupeng, Long Yusen, Han Zhaodong, Su Jiaming, Zhou Rui, Zhou Ziqing, He Huichan, Liu Shaoyou, Zhong Weide

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

组学整合分析发现 CRIP2 是前列腺癌中奥拉帕尼耐药性的关键介质。

Tian Weicheng, Li Yize, Xiao Haiyin, Cai Shanghua, Li Jinchuang, Wen Biyan, Tan Zeheng, Wu Zhenjie, Han Zhaodong, Deng Yulin, Wu Yongding, He Huichan, Ye Jianheng, Zhong Weide

A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy

一种独特的方法:基于仿生石墨炔的纳米平台结合铜凋亡和增强型化学动力疗法治疗前列腺癌

Xie, Wenjie; Zhang, Yixun; Xu, Qianfeng; Zhong, Guowei; Lin, Jundong; He, Huichan; Du, Qiuling; Tan, Huijing; Chen, Muqi; Wu, Zhenjie; Deng, Yulin; Han, Zhaodong; Lu, Jianming; Ye, Jianheng; Zou, Fen; Zhuo, Yangjia; Zhong, Weide